Thrombocythemia, Essential: Clinical Trials

3 trials for Thrombocythemia, Essential, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Unknown 3
Phase 11Unknown 1

Follow Thrombocythemia, Essential: new trials by email Literature Review of Thrombocythemia, Essential trials Research Report on Thrombocythemia, Essential

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Childhood and Adolescent Essential Thrombocythemia
Recombinant Interferon Alpha, Pegylated interferon alfa-2b - Essential Thrombocytopenia
Phase 2UnknownInstitute of Hematology & Blood Diseases Hospital, China402020-01-102024-07-03
A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia
HDAC inhibitor (MK-0683) - Polycythemia Vera, Essential Thrombocythemia
Phase 2UnknownCopenhagen University Hospital at Herlev602009-02-012011-12-12
CEP-701 (Lestaurtinib) in Myelofibrosis
CEP-701 (Lestaurtinib) - Myelofibrosis, Essential Thrombocythemia
Phase 1 / Phase 2UnknownRonald Hoffman602008-04-012014-11-26

Narrower conditions

Polycythemia Vera (2)  ·  Hematologic Diseases (1)  ·  Polycythemia (1)  ·  Primary Myelofibrosis (1)

Broader conditions

Blood Coagulation Disorders (3)  ·  Blood Platelet Disorders (3)  ·  Bone Marrow Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Hemorrhagic Disorders (3)  ·  Myeloproliferative Disorders (3)  ·  Thrombocytosis (3)  ·  Bone Marrow Neoplasms (2)  ·  Hematologic Diseases (2)  ·  Hematologic Neoplasms (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)

Interventions

Histone Deacetylase Inhibitors (1)  ·  Vorinostat (1)  ·  lestaurtinib (1)  ·  peginterferon alfa-2b (1)

Sponsors

Copenhagen University Hospital at Herlev (1)  ·  Institute of Hematology & Blood Diseases Hospital, China (1)  ·  Ronald Hoffman (1)

Countries

China (1)  ·  Denmark (1)  ·  Netherlands (1)  ·  Sweden (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Hans C Hasselbalch, MD (1)  ·  Lei Zhang, MD (1)  ·  Ronald Hoffman, MD (1)  ·  Rongfeng Fu (1)

Results publications

PMID 25563429

NIH funding

P01CA108671 (1)